Factorial design and development of solid lipid nanoparticles (SLN) for gene delivery

Journal of Nanoscience and Nanotechnology

Volumn 15, Issue 2, 2015, Pages 1793-1800

  Radaic, Allan ^a   De Paula, Eneida ^a   De Jesus, Marcelo Bispo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Factorial design; Gene delivery; Solid lipid nanoparticle

Indexed keywords

CELLS; DESIGN; DISEASES; GENE TRANSFER; GENES; MOLECULAR BIOLOGY; NANOPARTICLES; STEARIC ACID; UROLOGY;

COLLOIDAL STABILITY; FACTORIAL DESIGN; GENE DELIVERY; GENE DELIVERY SYSTEMS; PROSTATE CANCER CELLS; RESPONSE SURFACE METHODOLOGY; SOLID LIPID NANOPARTICLE (SLN); TRANSFECTION EFFICIENCY;

GENE THERAPY;

DNA; LIPID; LIPOSOME;

ANIMAL; CHEMISTRY; COMPUTER SIMULATION; DRUG DESIGN; FACTORIAL ANALYSIS; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; MALE; MOUSE; PROCEDURES; PROSTATE TUMOR; STATISTICAL MODEL; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COMPUTER SIMULATION; DNA; DRUG DESIGN; FACTOR ANALYSIS, STATISTICAL; GENETIC THERAPY; LIPIDS; LIPOSOMES; MALE; MICE; MODELS, STATISTICAL; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 84920836891     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2015.9002     Document Type: Article

References (30)

1. H. Cao, R. S. Molday, and J. Hu, Protein Cell 2, 973 (2011).
2. C. Sheridan, Nat. Biotechnol. 29, 121 (2011).
3. A. L. David and D. Peebles, Best Pract. Res. Clin. Obstet. Gynaecol. 22, 203 (2008).
4. X. Guo and L. Huang, Acc. Chem. Res. 45, 971 (2012).
5. M. Elsabahy, A. Nazarali, and M. Foldvari, Curr. Drug. Deliv. 8, 235 (2011).
6. F. Liu, L. M. Shollenberger, C. C. Conwell, X. Yuan, and L. Huang, J. Gene Med. 9, 613 (2007).
7. D. W. Pack, A. S. Hoffman, S. Pun, and P. S. Stayton, Nat. Rev. Drug Discov. 4, 581 (2005).
8. Z. Liu, Z. Zhong, G. Peng, S. Wang, X. Du, D. Yan, Z. Zhang, Q. He, and J. Liu, Drug Deliv. 16, 341 (2009).
9. T. T. Lobovkina, G. B. G. Jacobson, E. E. Gonzalez-Gonzalez, R. P. R. Hickerson, D. D. Leake, R. L. R. Kaspar, C. H. C. Contag, and R. N. R. Zare, ACS Nano 5, 9977 (2011).
10. S. Doktorovova, R. Shegokar, E. Rakovsky, E. Gonzalez-Mira, C. M. Lopes, A. M. Silva, P. Martins-Lopes, R. H. Müller, and E. B. Souto, Int. J. Pharm. 420, 341 (2011).
11. M. B. de Jesus, C. V. Ferreira, E. de Paula, D. Hoekstra, and I. S. Zuhorn, J. Control. Release 148, e89 (2010).
12. M. B. de Jesus, C. V. Ferreira, E. de Paula, D. Hoekstra, and I. S. Zuhorn, Drug Discov. Today 15, 1110 (2010).
13. S. B. Lim, A. Banerjee, and H. Önyüksel, J. Control Release 163, 34 (2012).
14. A. A. Attama, Recent Pat. Drug Deliv. Formul. 5, 178 (2011).
15. J. Pardeike, A. Hommoss, and R. H. Müller, Int. J. Pharm. 366, 170 (2009).
16. M. R. Gasco, Adv. Drug Deliv. Rev. 59, 377 (2007).
17. S. F. Taveira, L. M. P. de C. Araújo, D. C. A. S. de Santana, A. Nomizo, L. A. P. de Freitas, and R. F. V. Lopez, J. Biomed. Nanotech. 8, 219 (2012).
18. M. Shah and K. Pathak, AAPS Pharm. Sci. Tech. 11, 489 (2010).
19. P. M. S. Souza, F. A. Lobo, A. H. Rosa, and L. F. Fraceto, Quim Nova 35, 132 (2012).
20. M. de Jesus, A. Radaic, I. Zuhorn, and E. Paula, J. Nanopart. Res. 15, 1 (2013).
21. A. del Pozo-Rodríguez, D. Delgado, M. A. Solinís, A. R. Gascón, and J. L. Pedraz, Int. J. Pharm. 339, 261 (2007).
22. C. A. Schneider, W. S. Rasband, and K. W. Eliceiri, Nat. Rev. Mol. Cell Biol. 9, 671 (2012).
23. T. Mosmann, J. Immunol. Methods 65, 55 (1983).
24. W. C. Griffin, J. Soc. Cosmetic Chemists 1, 311 (1949).
25. Y.-C. Kuo and C.-C. Wang, Colloids Surf., B 76, 286 (2010).
26. W. Yu, C. Liu, J. Ye, W. Zou, N. Zhang, and W. Xu, Nanotechnology 20, 215102 (2009).
27. A. del Pozo-Rodríguez, D. Delgado, M. Á. Solinís, J. L. Pedraz, E. Echevarría, J. M. Rodríguez, and A. R. Gascon, Int. J. Pharm. 385, 157 (2010).
28. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan, J. Control. Release 114, 100 (2006).
29. J. Li, C. Ma, Y. Ma, Y. Li, W. Zhou, and P. Xu, Appl. Microbiol. Biotechnol. 74, 563 (2007).
30. B. Mishra, B. B. Patel, and S. Tiwari, Nanomedicine 6, 9 (2010).